Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag FDA proposes ending six-month primate tests for some antibodies, favoring human-relevant alternatives.

flag The FDA has proposed reducing or eliminating six-month primate toxicity tests for certain monoclonal antibody drugs, favoring human-relevant alternatives like computer models and lab-grown tissues. flag The draft guidance aims to speed drug development, cut costs, and improve accuracy by replacing outdated animal testing, which often fails to predict human responses. flag While animal advocates welcome the shift, critics caution against abrupt changes that could risk public health progress. flag The move aligns with broader efforts to modernize safety testing and reduce reliance on non-human primates, though final rules are pending public comment.

6 Articles

Further Reading